Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Phencyclidine Polyclonal Antibody

Sheep Polyclonal Antibody

Supplier:  Invitrogen™ PA175340

Catalog No. PIPA175340


Only null left
Add to Cart

Description

Description

Working Concentration: 1/16K. Sensitivity: 10 ng/mL PCP produces 89% inhibition in a competitive ELISA employing Phencyclidine (piperidyl,4) polyclonal antibody.

Phencyclidine is an illegal, hallucinogenic drug that was initially used as an anesthetic agent in the 1950s and early 1960s, but was then withdrawn in 1965 because of dissociative hallucinogenic effects that were often disturbing and sometimes severe and prolonged. The out-of-body intense psychological and behavioral effects of low doses of phencyclidine led to its abuse. In the late 1960s and 1970s, phencyclidine (angel dust) became a widely used hallucinogenic drug. The effects were often extreme, marked by acute psychosis and aggressive and violent behaviors, and overdoses led to many emergency room visits and deaths from status epilepticus, hyperthermia, rhabdomyolysis and subsequent renal, respiratory and hepatic failure. [National Center for Biotechnology Information. PubChem Compound Database; CID=6468].
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Phencyclidine
Polyclonal
PBS with 0.09% sodium azide; pH 7.2
Sheep
Purified
RUO
Chemical
Antibody
IgG
ELISA
Unconjugated
C17H25N; PCP
PCP(piperidyl,4)-BSA.
1 mg
Primary
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Chemical
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.